Back to News
Market Impact: 0.1
Gain Therapeutics, Inc. Appoints Jeanette Weidner as Vice President, Finance, Effective October 28, 2026
Source: Nasdaq
Management & Governance
Gain Therapeutics appointed Jeanette Weidner as Vice President, Finance, effective October 28, 2026. She will also serve as the company’s principal financial officer and principal accounting officer.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
GANX0.10
More News
- Norwegian shares surge 13% on earnings beat, guidance raise
- ECB’s Lagarde Steps Aside as European Economic Pressure Builds
- Walmart investigates Flipkart over employee kickback claims: Moneycontrol
- Thrive Holdings to acquire ADT for $7.6 billion in cash deal
- Alphabet Miss Revives AI Fears
- Norwegian Cruise Line stock jumps on earnings beat